Stock Market Cafe
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
Stock Market Cafe
No Result
View All Result
Home Trading News

Moderna CEO says people may need fourth Covid shot as efficacy of boosters likely to decline

by
January 6, 2022
in Trading News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

RELATED POSTS

Germany’s much-vaunted trade surplus disappears as import prices surge

Yum Brands says it is close to selling its Russian KFC business

A nurse prepares a syringe with a dose of the Moderna coronavirus disease (COVID-19) vaccine at Enfermera Isabel Zendal hospital in Madrid, Spain, July 23, 2021.
Juan Medina | Reuters

Moderna CEO Stephane Bancel on Thursday said the efficacy of boosters against Covid-19 will likely decline over time, and people may need a fourth shot in the fall of 2022 to increase their protection.

Bancel said people who received their boosters in the fall of 2021 will likely have enough protection to get them through the winter, when new infections surge as people gather indoors to escape the cold.

However, Bancel said the efficacy of boosters will probably decline over the course of several months, similar to what happened with the first two doses. The Moderna chief was interviewed by Goldman Sachs during the investment bank’s health-care CEO conference.

“I will be surprised when we get that data in the coming weeks that it’s holding nicely over time — I would expect that it’s not gonna hold great,” Bancel said, referring to the strength of the booster shots.

The world is currently suffering an unprecedented surge of infections due to omicron. The U.S., for example, is reporting a seven-day average of more than 574,000 new cases daily, according to a CNBC analysis of data from Johns Hopkins University.

The Moderna CEO expects another round of boosters will be necessary in the fall of 2022. He said governments, including the U.K. and South Korea, are already ordering the shots in preparation.

“I still believe we’re going to need boosters in the fall of ’22 and forward,” Bancel said, adding that people who are older or have underlying health conditions might need annual boosters for years to come.

“We have been saying that we believe first this virus is not going away,” Bancel said. “We’re gonna have to live with it.”

Moderna published preliminary data last month that showed its currently authorized 50 microgram booster shot increased the antibodies that block infection from omicron 37 fold. A 100 microgram booster increased those antibodies 83 fold.

CNBC Health & Science

Read CNBC’s latest global coverage of the Covid pandemic:

CDC panel recommends Pfizer boosters for 12- to 15-year-olds amid omicron surge

Live updates of CDC meeting on Pfizer’s Covid booster shots for adolescents

Omicron may have peaked or ‘plateaued’ in parts of the world, giving experts cause for optimism

Fauci says multiple preliminary studies find omicron is less severe than delta

Chicago cancels public school classes after teachers’ union votes for remote learning amid Covid surge

CDC declines to add Covid testing recommendation to updated isolation guidance despite criticism

Omicron makes up 95% of sequenced Covid cases in U.S. as infections hit pandemic record

Booster shots are playing an increasingly important role in public health strategies to control the virus since the protection from the original two shots have taken a significant blow from omicron.

Real-world data from the United Kingdom found that Moderna and Pfizer’s two-dose vaccines are only about 10% effective at preventing symptomatic infection from omicron 20 weeks after the second dose.

The same study, published by the U.K. Health Security Agency, found that booster doses are up to 75% effective at preventing symptomatic infection two weeks after receiving the shot.

However, the efficacy of booster shots starts to decline after about 4 weeks, according to the study. Boosters were 55% to 70% effective at preventing infection at weeks 5 to 9, and 40% to 50% effective 10 weeks after receiving the shot.

Pfizer CEO Albert Bourla told CNBC last month that people will likely need a fourth dose, and the shot may be need sooner than expected due to the omicron variant.

Bancel, during the Goldman Sachs interview, said omicron could accelerate the transition from the acute crisis caused by the virus to an endemic phase where enough people have immune protection so that Covid isn’t as disruptive to public life.

However, he also cautioned against predictions, noting that omicron, with its dozens of mutations, took most of the scientific community surprise. The data so far indicates the omicron is more transmissible but less severe than past strains.

However, a random mutation could change the course of the pandemic again, Bancel said.

“What is totally impossible to predict, is there a new mutation coming in a day, a week, three months that is worse in terms of severity of disease,” Bancel said. “That’s a piece that we’ll have to just be cautious about.”

ShareTweetPin

Related Posts

Germany’s much-vaunted trade surplus disappears as import prices surge

by
July 5, 2022
0

Germany trade entered negative territory in May, raising questions about the stability of its economy in the wake of Russia's...

Yum Brands says it is close to selling its Russian KFC business

by
July 5, 2022
0

In this article YUM A woman walks near closed KFC and McDonald's restaurants that suspended their business in Russia due...

Dow falls 700 points as Wall Street grapples with recession concerns

by
July 5, 2022
0

Traders on the floor of the NYSE, July 1, 2022. Source: NYSE Stock futures were lower early on Tuesday morning...

Seeking at Least 11% Dividend Yield? Analysts Suggest 2 Dividend Stocks to Buy

by
July 5, 2022
0

Insider Monkey 10 Best Bargain Stocks To Buy Right Now In this article, we discuss 10 best bargain stocks to...

Borrowers are on edge—will Biden cancel student debt or not? Here’s what’s going on.

by
July 5, 2022
0

This article is reprinted by permission from NerdWallet.  The “will he, won’t he” summer of student debt cancellation is upon us. The...

Next Post

Stock futures inch higher ahead of key jobs report

SpaceX says Starlink internet service has more than 145,000 users so far

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:

By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

MOST VIEWED

  • Crocs sees fourth-quarter sales up 42%, CEO Andrew Rees says 2021 was ‘exceptional year’

    0 shares
    Share 0 Tweet 0
  • Buying a car from the factory sounds expensive, but it can actually save you money. Here’s how to do it.

    0 shares
    Share 0 Tweet 0
  • Roth TSP vs. Roth IRA: How Do They Compare?

    0 shares
    Share 0 Tweet 0
  • The states that won’t tax military retirement in 2022

    0 shares
    Share 0 Tweet 0
  • Allbirds stock has plunged 50% in two months, now one top analyst says buy it

    0 shares
    Share 0 Tweet 0
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
All rights reserved by www.stockmarket-cafe.com
No Result
View All Result
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy

All rights reserved by www.stockmarket-cafe.com